# Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)

Study · id `cardio:ct-nct07594301` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07594301](<https://clinicaltrials.gov/study/NCT07594301>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07594301

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 234 participants.

## Technical summary

Registry record NCT07594301. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-19 (actual); primary completion 2028-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 234 participants (planned count; ClinicalTrials.gov record NCT07594301, source copy `cardio:ctgov-nct07594301-2026-05-22`, retrieved 2026-10-26)
- Started: 2026-05-19 (actual) (ClinicalTrials.gov record NCT07594301, source copy `cardio:ctgov-nct07594301-2026-05-22`, retrieved 2026-10-26)
- Primary completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07594301, source copy `cardio:ctgov-nct07594301-2026-05-22`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07594301, source copy `cardio:ctgov-nct07594301-2026-05-22`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07594301, source copy `cardio:ctgov-nct07594301-2026-05-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07594301-2026-05-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)
- Condition: Acute Ischemic Stroke
- Condition: Endovascular Thrombectomy
- Condition: Minocycline
- Condition: Posterior Circulation
- Condition: Arterial Occlusion
- Intervention (Drug): Minocycline hydrochloride capsule
- Intervention (Drug): Placebo capsules of Minocycline hydrochloride capsules
- Lead sponsor: Xiang Luo
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Xiang Luo (`cardio:org-xiang-luo`)

## Provenance

Content hash: a7f3d2bf7b78f713df29631d9fdba32c5da39feef2c954456b71f8566052447a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
